These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 39001644)

  • 1. Tumour-induced alterations in single-nucleus transcriptome of atrophying muscles indicate enhanced protein degradation and reduced oxidative metabolism.
    Agca S; Domaniku-Waraich A; Bilgic SN; Sucuoglu M; Dag M; Dogan SA; Kir S
    J Cachexia Sarcopenia Muscle; 2024 Oct; 15(5):1898-1914. PubMed ID: 39001644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EDA2R-NIK signalling promotes muscle atrophy linked to cancer cachexia.
    Bilgic SN; Domaniku A; Toledo B; Agca S; Weber BZC; Arabaci DH; Ozornek Z; Lause P; Thissen JP; Loumaye A; Kir S
    Nature; 2023 May; 617(7962):827-834. PubMed ID: 37165186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
    Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EDA2R-NIK signaling in cancer cachexia.
    Agca S; Kir S
    Curr Opin Support Palliat Care; 2024 Sep; 18(3):126-131. PubMed ID: 38801457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The time-course of cancer cachexia onset reveals biphasic transcriptional disruptions in female skeletal muscle distinct from males.
    Morena da Silva F; Lim S; Cabrera AR; Schrems ER; Jones RG; Rosa-Caldwell ME; Washington TA; Murach KA; Greene NP
    BMC Genomics; 2023 Jul; 24(1):374. PubMed ID: 37403010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
    Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-Induced Muscle Wasting Requires p38β MAPK Activation of p300.
    Sin TK; Zhang G; Zhang Z; Zhu JZ; Zuo Y; Frost JA; Li M; Li YP
    Cancer Res; 2021 Feb; 81(4):885-897. PubMed ID: 33355181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle-derived IL-1β regulates EcSOD expression via the NBR1-p62-Nrf2 pathway in muscle during cancer cachexia.
    Yamada M; Warabi E; Oishi H; Lira VA; Okutsu M
    J Physiol; 2024 Sep; 602(17):4215-4235. PubMed ID: 39167700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
    Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
    Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy.
    Reed SA; Sandesara PB; Senf SM; Judge AR
    FASEB J; 2012 Mar; 26(3):987-1000. PubMed ID: 22102632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting.
    Zhang G; Jin B; Li YP
    EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
    Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
    Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet-induced obesity does not exacerbate cachexia in male mice bearing Lewis-lung carcinoma tumors.
    Beaudry AG; Law ML; Gilley-Connor KR; Buley H; Dungan CM; Nascimento CMC; Vichaya EG; Wiggs MP
    Am J Physiol Regul Integr Comp Physiol; 2024 Mar; 326(3):R254-R265. PubMed ID: 38252513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myostatin gene inactivation prevents skeletal muscle wasting in cancer.
    Gallot YS; Durieux AC; Castells J; Desgeorges MM; Vernus B; Plantureux L; Rémond D; Jahnke VE; Lefai E; Dardevet D; Nemoz G; Schaeffer L; Bonnieu A; Freyssenet DG
    Cancer Res; 2014 Dec; 74(24):7344-56. PubMed ID: 25336187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin K activity controls cachexia-induced muscle atrophy via the modulation of IRS1 ubiquitination.
    Meng X; Huang Z; Inoue A; Wang H; Wan Y; Yue X; Xu S; Jin X; Shi GP; Kuzuya M; Cheng XW
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1197-1209. PubMed ID: 35098692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle weakness and mitochondrial stress occur before severe metastasis in a novel mouse model of ovarian cancer cachexia.
    Delfinis LJ; Ogilvie LM; Khajehzadehshoushtar S; Gandhi S; Garibotti MC; Thuhan AK; Matuszewska K; Pereira M; Jones RG; Cheng AJ; Hawke TJ; Greene NP; Murach KA; Simpson JA; Petrik J; Perry CGR
    Mol Metab; 2024 Aug; 86():101976. PubMed ID: 38925248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel orthotopic mouse model replicates human lung cancer cachexia.
    van de Worp WRPH; Theys J; González AS; van der Heyden B; Verhaegen F; Hauser D; Caiment F; Smeets HJM; Schols AMWJ; van Helvoort A; Langen RCJ
    J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1410-1423. PubMed ID: 37025071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.